Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Maison Solutions Inc. (NASDAQ: MSS); Methode Electronics, Inc. (NYSE: MEI); Treace Medical Concepts, Inc. (NASDAQ: TMCI); and Xponential Fitness Inc. (NYSE: XPOF)

Stock Information for Cibus Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Cibus Inc.

Investor Alert: Johnson Fistel Investigates Methode Electronics, Integral Ad Science, Manhattan Associates, and Crocs on Behalf of Shareholders
Methode Electronics to Release Fourth Quarter and Full Year Fiscal 2025 Results on Wednesday, July 9, 2025
Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Maison Solutions Inc. (NASDAQ: MSS); Methode Electronics, Inc. (NYSE: MEI); Treace Medical Concepts, Inc. (NASDAQ: TMCI); and Xponential Fitness Inc. (NYSE: XPOF)
SHAREHOLDER ALERT: Morris Kandinov Investigating IRTC, HAYW, MEI, and MRCY; Shareholders are Encouraged to Contact the Firm
Notice to Long-Term Shareholders of Dick's Sporting Goods, Inc. (NYSE: DKS); Maison Solutions, Inc. (NASDAQ: MSS); Mercury Systems, Inc. (NASDAQ: MRCY); and Methode Electronics, Inc. (NYSE: MEI): Grabar Law Office is Investigating Claims on Your Behalf
Alert: Grabar Law Office is Investigating Claims on Behalf Long-Term Shareholders of Methode Electronics, Inc. (NYSE: MEI); Treace Medical Concepts, Inc. (NASDAQ: TMCI); Virtu Financial Inc. (NASDAQ: VIRT); and West Pharmaceutical Services, Inc.
Investor Alert: Super Micro Computer, Methode Electronics, Regeneron Pharmaceuticals, and New Fortress Energy: Johnson Fistel, PLLP Investigates Claims on Behalf of Investors
Investor Alert: Super Micro Computer, Methode Electronics, Inc., SentinelOne, and New Fortress Energy: Johnson Fistel, PLLP Investigates Claims on Behalf of Investors

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.